Literature DB >> 12749474

Update: Severe acute respiratory syndrome--United States, 2003.

.   

Abstract

CDC continues to work with the World Health Organization (WHO) and other partners to investigate cases of severe acute respiratory syndrome (SARS). This report updates information on reported SARS cases worldwide and among U.S. residents and summarizes information on one additional case with laboratory evidence of infection with the SARS-associated coronavirus (SARS-CoV).

Entities:  

Mesh:

Year:  2003        PMID: 12749474

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  The best protection.

Authors:  John H Lange
Journal:  CMAJ       Date:  2003-06-10       Impact factor: 8.262

2.  Disease-specific B Cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens.

Authors:  I-Ju Liu; Po-Ren Hsueh; Chin-Tarng Lin; Chien-Yu Chiu; Chuan-Liang Kao; Mei-Ying Liao; Han-Chung Wu
Journal:  J Infect Dis       Date:  2004-07-15       Impact factor: 5.226

3.  SARS: the challenge of emerging pathogens to the intensivist.

Authors:  Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2003-06       Impact factor: 17.440

4.  SARS surveillance during emergency public health response, United States, March-July 2003.

Authors:  Stephanie J Schrag; John T Brooks; Chris Van Beneden; Umesh D Parashar; Patricia M Griffin; Larry J Anderson; William J Bellini; Robert F Benson; Dean D Erdman; Alexander Klimov; Thomas G Ksiazek; Teresa C T Peret; Deborah F Talkington; W Lanier Thacker; Maria L Tondella; Jacquelyn S Sampson; Allen W Hightower; Dale F Nordenberg; Brian D Plikaytis; Ali S Khan; Nancy E Rosenstein; Tracee A Treadwell; Cynthia G Whitney; Anthony E Fiore; Tonji M Durant; Joseph F Perz; Annemarie Wasley; Daniel Feikin; Joy L Herndon; William A Bower; Barbara W Klibourn; Deborah A Levy; Victor G Coronado; Joanna Buffington; Clare A Dykewicz; Rima F Khabbaz; Mary E Chamberland
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

5.  Border screening for SARS.

Authors:  Ronald K St John; Arlene King; Dick de Jong; Margaret Bodie-Collins; Susan G Squires; Theresa W S Tam
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

6.  SARS and its impact on current and future Emergency Department operations.

Authors:  Chad T Marley; Marc E Levsky; Timothy S Talbot; Christopher S Kang
Journal:  J Emerg Med       Date:  2004-05       Impact factor: 1.484

Review 7.  Medical treatment of viral pneumonia including SARS in immunocompetent adult.

Authors:  V C C Cheng; B S F Tang; A K L Wu; C M Chu; K Y Yuen
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.